Abstract
Both obesity and equine metabolic syndrome are being increasingly recognised. The underlying endocrine abnormality, insulin dysregulation, represents a high risk for endocrinopathic (hyperinsulinaemia-associated) laminitis. Early recognition and prompt treatment of the condition is crucial for the prevention of laminitis, a potentially severe disease that can have a fatal outcome. This article summarises current understanding of metabolic syndrome and its relationship to obesity. Current guidelines regarding early clinical recognition and corroborating diagnostic tests have been provided.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
